NRP1 and COVID-19: Although current evidence in support is scarce, it may be hypothesized that such a mechanism could also occur with respect to NRP-1 and perhaps contribute to the development of neurological and cardiovascular symptoms of long COVID-19 or some side effects of COVID-19 vaccines.